EUVIMEDEUVIMED entdecken
Crossref

Timosaponin A1 exerts antitumor effect against osteosarcoma by targeting JAK2/STAT3 signaling pathway

Jia Shi, Yixuan Xu, Tongtong Liu, Weisong Zhao, Yinghua Gao, Tao Zhang, Yingqi Hua

The International Journal of Biochemistry & Cell Biology · 2026

DOI: 10.1016/j.biocel.2026.106997 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The International Journal of Biochemistry & Cell Biology, 2026. Verfasst von Jia Shi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Shanghai Bone Tumor Institution, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 100 Haining …. Hauptthemen laut MEDLINE: Saponins, STAT3 Transcription Factor, Janus Kinase 2, Osteosarcoma. Die Arbeit nennt 33 Literaturangaben. Gefördert von: School of Medicine, Shanghai Jiao Tong University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Novel therapeutic agents are urgently needed since osteosarcoma is a highly aggressive bone tumor primarily affecting children and adolescents that remains poorly responsive to conventional chemotherapy. Persistent aberrant activation of STAT3, particularly via the IL-6/JAK2/STAT3 signaling axis, is frequently observed across multiple malignancies and correlates with poor prognosis, making STAT3 inhibition a compelling therapeutic strategy for osteosarcoma. In this study, we provide the first evidence that Timosaponin A1 (TA1), a naturally occurring saponin isolated from Anemarrhena asphodeloides Bge., suppresses JAK2/STAT3 signaling in osteosarcoma. By inducing cell-cycle arrest and apoptosis, while inhibiting migration and invasion, TA1 markedly reduced the malignant phenotype of osteosarcoma cells. Mechanistically, TA1 directly bound to JAK2, thereby inhibiting STAT3 transcriptional activity and reducing the phosphorylation levels of JAK2 and STAT3. Furthermore, TA1 effectively inhibited IL-6-induced STAT3 phosphorylation and nuclear translocation. Genetic knockdown of STAT3 significantly impaired osteosarcoma cell proliferation and attenuated the inhibitory effects of TA1, supporting a STAT3-dependent mechanism. Finally, an orthotopic tibial osteosarcoma xenograft model in nude mice was used to evaluate the therapeutic potential of TA1 in vivo. Together, our findings demonstrate that TA1 exerts potent antitumor effects by suppressing aberrant STAT3 activation, highlighting its potential as a promising therapeutic candidate for osteosarcoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SaponinsSTAT3 Transcription FactorJanus Kinase 2OsteosarcomaSignal TransductionSteroidsBone NeoplasmsHumansAnimalsMice, NudeCell Line, TumorMiceCell ProliferationXenograft Model Antitumor AssaysApoptosisMice, Inbred BALB CCell MovementPhosphorylation

Stichwörter der Autor:innen

IL-6/JAK2/STAT3 signalingOsteosarcomaSTAT3Timosaponin A1

Substanzen

SaponinsSTAT3 Transcription FactorJanus Kinase 2JAK2 protein, humanSTAT3 protein, humanSteroids

Autor:innen und Institutionen

  • Department of Orthopedics, Shanghai Bone Tumor Institution, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 100 Haining Street, Shanghai 200080, China.
  • Department of Orthopedics, Shanghai Bone Tumor Institution, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 100 Haining Street, Shanghai 200080, China. Electronic address: zhangtaoabc@2008.s…
  • Department of Orthopedics, Shanghai Bone Tumor Institution, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 100 Haining Street, Shanghai 200080, China. Electronic address: yhua@shsmu.edu.cn.

Förderung

  • School of Medicine, Shanghai Jiao Tong University

Zitieren

APA

Shi, J., Xu, Y., Liu, T., Zhao, W., Gao, Y., Zhang, T., & Hua, Y. (2026). Timosaponin A1 exerts antitumor effect against osteosarcoma by targeting JAK2/STAT3 signaling pathway. The International Journal of Biochemistry & Cell Biology. https://doi.org/10.1016/j.biocel.2026.106997

Vancouver

Shi J, Xu Y, Liu T, Zhao W, Gao Y, Zhang T, et al. Timosaponin A1 exerts antitumor effect against osteosarcoma by targeting JAK2/STAT3 signaling pathway. The International Journal of Biochemistry & Cell Biology. 2026. doi:10.1016/j.biocel.2026.106997

BibTeX
@article{Shi2026,
  author = {Shi, Jia and Xu, Yixuan and Liu, Tongtong and Zhao, Weisong and Gao, Yinghua and Zhang, Tao and Hua, Yingqi},
  title = {Timosaponin A1 exerts antitumor effect against osteosarcoma by targeting JAK2/STAT3 signaling pathway},
  journal = {The International Journal of Biochemistry & Cell Biology},
  year = {2026},
  doi = {10.1016/j.biocel.2026.106997}
}
Kostenlos starten →